Your institution may have access to this item. Find your institution then sign in to continue.
Title
Randomized Phase II Study of Gemcitabine Administered at a Fixed Dose Rate or in Combination With Cisplatin, Docetaxel, or Irinotecan in Patients With Metastatic Pancreatic Cancer: CALGB 89904
Authors
Kulke, Matthew H.; Tempero, Margaret A.; Niedzwiecki, Donna; Hollis, Donna R.; Kindler, Hedy L.; Cusnir, Michael; Enzinger, Peter C.; Gorsch, Stefan M.; Goldberg, Richard M.; Mayer, Robert J.
Publication
Journal of Clinical Oncology, 2009, Vol 27, Issue 33, p5506